Skip to contentApplication 021825
- Type
- NDA
- Sponsor
- CHIESI
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | FERRIPROX | DEFERIPRONE | TABLET;ORAL | 500MG | Yes | Yes |
| 002 | FERRIPROX | DEFERIPRONE | TABLET;ORAL | 1GM | Yes | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 10122-100 | FERRIPROX | deferiprone | Chiesi USA, Inc. | NDA | Current |
| 10122-100 | FERRIPROX | deferiprone | Chiesi USA, Inc. | NDA | Current |
| 10122-100 | FERRIPROX | deferiprone | Chiesi USA, Inc. | NDA | Current |
| 10122-100 | FERRIPROX | deferiprone | Chiesi USA, Inc. | NDA | Current |
| 10122-103 | FERRIPROX | DEFERIPRONE | Chiesi USA, Inc. | NDA | Current |
| 10122-103 | FERRIPROX | DEFERIPRONE | Chiesi USA, Inc. | NDA | Current |
| 10122-103 | FERRIPROX | DEFERIPRONE | Chiesi USA, Inc. | NDA | Current |
| 10122-103 | FERRIPROX | DEFERIPRONE | Chiesi USA, Inc. | NDA | Current |
| 52609-0006 | FERRIPROX | deferiprone | ApoPharma USA, Inc. | NDA | Current |
| 52609-0006 | FERRIPROX | deferiprone | ApoPharma USA, Inc. | NDA | Current |
| 52609-0006 | FERRIPROX | deferiprone | ApoPharma USA, Inc. | NDA | Current |
| 52609-0007 | FERRIPROX | deferiprone | ApoPharma USA, Inc. | NDA | Current |
| 52609-0007 | FERRIPROX | deferiprone | ApoPharma USA, Inc. | NDA | Current |
| 52609-0007 | FERRIPROX | deferiprone | ApoPharma USA, Inc. | NDA | Current |